Literature DB >> 32925599

Presepsin Values Predict Septic Acute Kidney Injury, Acute Respiratory Distress Syndrome, Disseminated Intravascular Coagulation, and Shock.

Yuichiro Shimoyama1, Osamu Umegaki1, Noriko Kadono1, Toshiaki Minami2.   

Abstract

BACKGROUND: Sepsis remains a major cause of mortality in critically ill patients. This study aimed to determine whether presepsin is a predictor of septic acute kidney injury (AKI), acute respiratory distress syndrome (ARDS), disseminated intravascular coagulation (DIC), and shock.
METHODS: A total of 83 adult patients diagnosed with sepsis were prospectively examined. Presepsin values were measured immediately after intensive care unit (ICU) admission and on Days 2, 3, and 5 after ICU admission. Glasgow Prognostic Score (GPS), neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, Prognostic Index, and Prognostic Nutritional Index were also examined at baseline. For category classification, total scores were calculated (hereafter, "inflammation-presepsin scores [iPS]") as follows: a score of 1 was assigned if the presepsin value and inflammation-based prognostic scores at baseline were above cutoffs determined by receiver operating characteristic (ROC) curve analysis for 28-day mortality; a score of 0 was assigned if they were below the cutoffs (total score range, 0-2 points). Presepsin values, inflammation-based prognostic scores, and iPS were compared between patients with septic AKI, ARDS, DIC, or shock and those without these disorders.
RESULTS: ROC curve analyses identified the following variables as predictors: presepsin on Days 1 and 2 for septic AKI; presepsin on Days 1 to 3; and iPS-GPS for septic ARDS; and presepsin on Day 2 and Δpresepsin (Day 2-Day 1) for septic DIC. Multivariate analysis revealed presepsin on Day 2 to be a predictor of septic DIC.
CONCLUSION: Presepsin is a predictor of septic AKI, ARDS, and DIC. Combining presepsin values with GPS improved the specificity for predicting septic ARDS relative to using baseline presepsin values alone.
Copyright © 2020 by the Shock Society.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 32925599     DOI: 10.1097/SHK.0000000000001664

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  6 in total

1.  Presepsin and platelet to lymphocyte ratio predict the progression of septic subclinical acute kidney injury to septic acute kidney injury: a pilot study.

Authors:  Yuichiro Shimoyama; Osamu Umegaki; Noriko Kadono; Toshiaki Minami
Journal:  BMC Res Notes       Date:  2022-06-20

2.  Serum stratifin and presepsin as candidate biomarkers for early detection of COVID-19 disease progression.

Authors:  Noriaki Arakawa; Shinichiro Matsuyama; Masaru Matsuoka; Isao Kitamura; Keiko Miyashita; Yutaro Kitagawa; Kazuo Imai; Kumiko Ogawa; Takuya Maeda; Yoshiro Saito; Chihiro Hasegawa
Journal:  J Pharmacol Sci       Date:  2022-06-13       Impact factor: 3.578

3.  Presepsin Predicts Severity and Secondary Bacterial Infection in COVID-19 by Bioinformatics Analysis.

Authors:  Yufei Chang; Linan Liu; Hui Wang; Jinghe Liu; Yuwei Liu; Chunjing Du; Mingxi Hua; Xinzhe Liu; Jingyuan Liu; Ang Li
Journal:  Comput Math Methods Med       Date:  2022-09-06       Impact factor: 2.809

4.  Presepsin and prognostic nutritional index are predictors of septic acute kidney injury, renal replacement therapy initiation in sepsis patients, and prognosis in septic acute kidney injury patients: a pilot study.

Authors:  Yuichiro Shimoyama; Osamu Umegaki; Noriko Kadono; Toshiaki Minami
Journal:  BMC Nephrol       Date:  2021-06-12       Impact factor: 2.388

Review 5.  Presepsin as a Diagnostic and Prognostic Biomarker in Sepsis.

Authors:  Dimitrios Velissaris; Nicholas Zareifopoulos; Vasileios Karamouzos; Evangelos Karanikolas; Charalampos Pierrakos; Ioanna Koniari; Menelaos Karanikolas
Journal:  Cureus       Date:  2021-05-13

6.  Prediction of Postoperative Sepsis Based on Changes in Presepsin Levels of Critically Ill Patients with Acute Kidney Injury after Abdominal Surgery.

Authors:  Chang Hwan Kim; Eun Young Kim
Journal:  Diagnostics (Basel)       Date:  2021-12-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.